Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001544227-20-000033

Options or other derivatives

  • Director acquired 12,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Gallagher Carol Giltner Director 2020-06-22 Grant or award · Stock Option (right to buy) +12,000 12,000 D
Loading xslF345X03/wf-form4_159291041152553.xml…